Primary Open Angle Glaucoma clinical trials
28 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Comparative, Randomized, Investigator-blind, Active-controlled, Parallel-group, Multicenter, Clinical Endpoint Study
- A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
- Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
- Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma
- Clarifying the Optimal Application of SLT Therapy Trial
- Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
- Hydrus® Microstent New Enrollment Post-Approval Study
- Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
- Caffeine Consumption in Glaucoma Patients and Healthy Subjects
- Perimetric Testing With Virtual Reality
- DSLT for Reducing Medication in Glaucoma
- DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma
- Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
- A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
- Diagnostic Innovations in Glaucoma Study
- Tied Tube Trial in Glaucoma Surgery
- Adaptive Optics Retinal Imaging
- Rocklatan vs Latanoprost Post-DSLT
- Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
- Direct Selective Laser Trabeculoplasty (DSLT) for Patients With Glaucoma or Ocular Hypertension Previously Treated With SLT
- The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
- Comparison of Goniotomy Device Outcomes in Combined Phacoemulsification-goniotomy Surgeries
- Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)
- Topical Insulin for Glaucoma (TING2)
- Smart Soft Contact Lenses for Monitoring Glaucoma
- Effect of Rhopressa on Intraocular Pressure (IOP) in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension Post-SLT
- A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
- A Real-World Evidence Study of Goniotomy With the C-REX™ Instrument in Patients With Primary Open Angle Glaucoma
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Primary Open Angle Glaucoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.